Solid Tumors

Reprogramming Tumor Immunity by Targeting Metabolic Checkpoints

Tumors impose metabolic stress that drives maladaptive immunometabolic states and suppresses effective anti-tumor responses.

We target metabolic checkpoints to overcome immune suppression, reshape tumor metabolism and restore effective antitumor immunity.

Overcoming Resistance

Restores responsiveness by targeting metabolic mechanisms that drive treatment resistance.

Enhancing Immune Quality

Strengthens the cytotoxic activity of immune cells to enable more effective tumor control.

Improved response to immunotherapy

Addresses metabolic barriers that limit responsiveness to immune checkpoint therapies.

Broad Tumor Applicability

Targets a shared metabolic vulnerability across tumor types and microenvironments.

Unlocking Immune Potential with
Innovative Metabolic Reprogramming

Pilatus Biosciences

Pilatus Biosciences SA
Route de la Corniche 6
1066 Epalinges
Vaud - SWITZERLAND

Pilatus Biosciences Corp
17F-1, No. 508, Section 7,
Zhongxiao East Road,
Nangang District,
Taipei City 115, Taiwan

Pilatus Biosciences HK Limited
Unit A, 22/F,
Wing Cheong Comm. Bldg.,
23 Jervois St., Sheung Wan,
Hong Kong

info@pilatusbio.com

Links

About Oncology Chronic Diseases Pipeline Our Team Business
Development Scientific
Collaboration Latest News Careers

© 2025 Pilatus Biosciences. All Rights Reserved.